FDA Keeps Door Open To Help Observational Studies Work For Health Claims
• By Elizabeth Crawford
FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
